<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
placeholder

NIH research network to evaluate emerging cancer screening technologies

Eight groups have received funding from the National Cancer Institute (NCI), part of NIH, to carry out the initial activities of the network.

In 2024, the network will launch a pilot study, known as the Vanguard Study on Multi-Cancer Detection, to address the feasibility of using multi-cancer detection (MCD) tests in future randomized controlled trials.

Topics: Press Coverage

Comments

Related Stories